PubMed · 7527722
Acellular and cellular hemoglobin solutions as vasoconstrictive factor.
Abstract
The inhibitory effects of acellular and cellular hemoglobin (Hb) solutions on endothelium-dependent vasorelaxation were investigated in rabbit thoracic aortic strips. As acellular Hb solutions, 2,3-diphosphoglycerate (DPG)-depleted Hb and pyridoxylated Hb were examined. Cellular Hb solutions included washed human fresh red cells and liposome Hb encapsulated with pyridoxal-5'-phosphate (PLP). The tissues were precontracted with phenylephrine (PE), after which acetylcholine (ACh) was added to elicit a steady-state relaxation. Acellular Hb solutions cumulatively reversed ACh-induced relaxation, and these inhibitory effects reached a plateau at 10 micrograms/ml. Increasing oxygen affinity by pyridoxylation had little effect on this. In contrast, both red cells and liposome Hb solution showed moderate inhibitory effects, and they reached a plateau at 1 mg/ml. These findings indicate that acellular Hb solutions are more potent inhibitors than cellular Hb solutions by a factor of about 100, and that the encapsulation of Hb is a preferable method to mimic the red cell.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
K Nakai, N Matsuda, M Amano, T Ohta, S Tokuyama, K Akama, Y Kawakami, E Tsuchida, S Sekiguchi. 1994. Acellular and cellular hemoglobin solutions as vasoconstrictive factor.. https://doi.org/10.3109/10731199409117884
Cite the original work for its findings. Save a collection to share your selection of sources.